Polycystic Ovary Syndrome and Liraglutide

NCT01899430 · Completed

Last updated 2026-05-28

This clinical trial tested the effect of the medication liraglutide on body weight in women with polycystic ovary syndrome (PCOS) and obesity.

Status Completed The study has finished.

Phase Phase 4 Monitors a drug already on the market.

Type Interventional (clinical trial)

Design Randomized, open-label (no blinding) treatment study

Participants 32 people

Who can join Ages 18–55 · female only

Timeline Started 2011-11 · est. completion 2013-04

Where 1 site · Slovenia

What this study is testing ClinicalTrials.gov NCT01899430 ↗

Description as written by the study sponsor.

The purpose of this study was to determine whether liraglutide is more effective than metformin in the treatment of obese women with newly diagnosed polycystic ovary syndrome (PCOS). We anticipated greater changes in body weight in patients treated with liraglutide than in those treated with metformin.

Treatments tested

liraglutide also known as Victoza 6 mg/ml solution for injection in pre-filled pen Drug
metformin also known as Glucophage tablets Drug

Main thing measured	The main outcome was change in body weight.
Sponsor	University Medical Centre Ljubljana
Conditions studied	PCOS, Obesity
GLP-1 drugs	liraglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT01899430 ↗